PROG Rapid Quantitative Test
- UID
- IMP/IVD/2022/000074_de2caec82c084c773e5b577be9ab7d55_8dbbfff199e1f50d1b4d1fe0a183cf5b
- Device class
- Class B
- Brand name
- Glycated Hemoglobin
- License holder
- FINOVA HEALTHCARE PRIVATE LIMITED
- Approving authority
- CDSCO
- Product information
- The Aehealth Progesterone Rapid Quantitative Test is a fluorescence immunoassay used along with Aehealth FIA System for quantitative determination of progesterone concentration in human whole blood, serum or plasma specimen. The test is used as an aid to track ovulation, monitor the effect of progesterone therapies and in early pregnancy to help diagnose an ectopic or failing pregnancy
PROG Rapid Quantitative Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000074_de2caec82c084c773e5b577be9ab7d55_8dbbfff199e1f50d1b4d1fe0a183cf5b. This device is marketed under the brand name Glycated Hemoglobin. The license holder is FINOVA HEALTHCARE PRIVATE LIMITED, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.